Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome-Reference-Cited by-同舟云学术

Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome

Published:2020-02-25 Issue:8 Volume:323 Page:725
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Ranieri V. Marco¹,Pettilä Ville²,Karvonen Matti K.³,Jalkanen Juho³,Nightingale Peter⁴,Brealey David⁵,Mancebo Jordi⁶,Ferrer Ricard⁷,Mercat Alain⁸,Patroniti Nicolò⁹,Quintel Michael¹⁰,Vincent Jean-Louis¹¹,Okkonen Marjatta²,Meziani Ferhat¹²,Bellani Giacomo¹³,MacCallum Niall⁵,Creteur Jacques¹¹,Kluge Stefan¹⁴,Artigas-Raventos Antonio¹⁵,Maksimow Mikael³,Piippo Ilse³,Elima Kati¹⁶,Jalkanen Sirpa¹⁶,Jalkanen Markku³,Bellingan Geoff⁵,

Affiliation:

1. Alma Mater Studiorum–Università di Bologna, Dipartimento di Scienze Mediche e Chirurgiche, Anesthesia and Intensive Care Medicine, Policlinico di Sant’Orsola, Bologna, Italy

2. Division of Intensive Care, Department of Anesthesiology, Intensive Care, and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

3. Faron Pharmaceuticals Ltd, Turku, Finland

4. Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom

5. Critical Care, University College London Hospitals, NHS Foundation Trust and National Institute for Health Research Biomedical Research Centre at University College London Hospitals NHS Foundation Trust and University College London, London, United Kingdom

6. Department of Intensive Care, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain

7. Department of Intensive Care/SODIR Research Group–VHIR Hospital Universitari Vall d’Hebron UCI, Barcelona, Spain

8. Médecine Intensive-Réanimation CHU d’Angers, Université d’Angers, Angers, France

9. Dipartimento di scienze diagnostiche e integrate, Università degli studi di Genova, Genova, Italy

10. Anesthesiology and Operative Intensive Care Medicine, Universitätsmedizin Göttingen, Göttingen, Germany

11. Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium

12. Université de Strasbourg (UNISTRA), Faculté de Médecine, Hôpitaux universitaires de Strasbourg, Nouvel Hôpital Civil, Service de réanimation, Strasbourg, France

13. Azienda Ospedaliera San Gerardo, Milan, Italy

14. Department of Intensive Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

15. Corporacion Sanitaria Universitaria Parc Tauli CIBER Enfermedades Respiratorias Autonomous University of Barcelona, Sabadell, Spain

16. Medicity research Laboratory, University of Turku, Turku, Finland

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2761314/jama_ranieri_2020_oi_190157.pdf

Reference26 articles.

1. Acute respiratory distress syndrome: the Berlin Definition.;Ranieri;JAMA,2012

2. Acute respiratory distress syndrome.;Matthay;Nat Rev Dis Primers,2019

3. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries.;Bellani;JAMA,2016

4. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.;Ohta;Nature,2001

5. Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia.;Thompson;J Exp Med,2004

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjunctive Therapies in Acute Respiratory Distress Syndrome;Critical Care Clinics;2023-12

2. Pharmacologic Treatments in Acute Respiratory Failure;Critical Care Clinics;2023-12

3. Anti-inflammatory therapies for acute respiratory distress syndrome;Expert Opinion on Investigational Drugs;2023-11-27

4. Real‐world causal evidence for planned predictive enrichment in critical care trials: A scoping review;Acta Anaesthesiologica Scandinavica;2023-08-30

5. Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy–controlled, phase 2 multicenter study (ONE-BRIDGE);Stem Cell Research & Therapy;2023-08-22